WO2009062036A3 - Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables - Google Patents

Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables Download PDF

Info

Publication number
WO2009062036A3
WO2009062036A3 PCT/US2008/082802 US2008082802W WO2009062036A3 WO 2009062036 A3 WO2009062036 A3 WO 2009062036A3 US 2008082802 W US2008082802 W US 2008082802W WO 2009062036 A3 WO2009062036 A3 WO 2009062036A3
Authority
WO
WIPO (PCT)
Prior art keywords
processes
pharmaceutically acceptable
acceptable salts
preparing
levocetirizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/082802
Other languages
English (en)
Other versions
WO2009062036A2 (fr
Inventor
Srinivasan Thirumalai Rajan
Uppala Venkata Bhaskara Rao
Akundi Surya Prabhakar
Joga Rajender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2009062036A2 publication Critical patent/WO2009062036A2/fr
Publication of WO2009062036A3 publication Critical patent/WO2009062036A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des procédés de préparation de dichlorhydrate de lévocétirizine.
PCT/US2008/082802 2007-11-09 2008-11-07 Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables Ceased WO2009062036A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN2575CH2007 2007-11-09
IN2575/CHE/2007 2007-11-09
US5749608P 2008-05-30 2008-05-30
US61/057,496 2008-05-30

Publications (2)

Publication Number Publication Date
WO2009062036A2 WO2009062036A2 (fr) 2009-05-14
WO2009062036A3 true WO2009062036A3 (fr) 2009-07-16

Family

ID=40626447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/082802 Ceased WO2009062036A2 (fr) 2007-11-09 2008-11-07 Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables

Country Status (1)

Country Link
WO (1) WO2009062036A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106187920A (zh) * 2016-07-15 2016-12-07 苏州东瑞制药有限公司 一种盐酸左西替利嗪片的有关物质及其分析检测方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012101648A1 (fr) * 2011-01-24 2012-08-02 Havaldar Freddy H Nouveau procédé de synthèse de 2-méthoxy-5-[(2r)-2-(4-alkylpipérazin-l-yl)propyl]-benzènesulfonamide énantiomériquement pur
CN104045607B (zh) * 2014-05-21 2016-04-13 丽珠医药集团股份有限公司 一种盐酸西替利嗪的纯化方法
CN105954419B (zh) * 2016-06-01 2018-02-06 重庆华邦胜凯制药有限公司 Hplc法分离测定盐酸左西替利嗪及其对映异构体的方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法
CN117209453A (zh) * 2023-08-24 2023-12-12 迪嘉药业集团股份有限公司 一种盐酸左西替利嗪中间体的制备及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058146A1 (fr) * 1981-02-06 1982-08-18 U C B, S.A. Nouveaux acides 2-(4-(diphénylméthyl)-1-pipérazinyl)-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
GB2225321A (en) * 1988-11-23 1990-05-30 Ucb Sa Process for preparation of a 1-piperazine-ethoxyacetic acid
WO1999052553A1 (fr) * 1998-04-14 1999-10-21 Sepracor Inc. Methodes, et compositions afferentes, d'utilisation de cetirizine en combinaison avec des inhibiteurs de leucotriene pour traiter des troubles consecutifs a l'inhibition de leucotriene
US6046332A (en) * 1996-07-11 2000-04-04 Tao; Yong Methods for the manufacture of cetirizine
WO2000052000A1 (fr) * 1999-03-04 2000-09-08 A/S Gea Farmaceutisk Fabrik Procede de preparation de composes d'acide acetique 2-{2-[4-(diphenylmethyl)-1-piperazinyl]ethoxy} ou de sels de ceux-ci

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058146A1 (fr) * 1981-02-06 1982-08-18 U C B, S.A. Nouveaux acides 2-(4-(diphénylméthyl)-1-pipérazinyl)-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
GB2225321A (en) * 1988-11-23 1990-05-30 Ucb Sa Process for preparation of a 1-piperazine-ethoxyacetic acid
US6046332A (en) * 1996-07-11 2000-04-04 Tao; Yong Methods for the manufacture of cetirizine
WO1999052553A1 (fr) * 1998-04-14 1999-10-21 Sepracor Inc. Methodes, et compositions afferentes, d'utilisation de cetirizine en combinaison avec des inhibiteurs de leucotriene pour traiter des troubles consecutifs a l'inhibition de leucotriene
US6790849B2 (en) * 1998-04-14 2004-09-14 Sepracor Inc. Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants
WO2000052000A1 (fr) * 1999-03-04 2000-09-08 A/S Gea Farmaceutisk Fabrik Procede de preparation de composes d'acide acetique 2-{2-[4-(diphenylmethyl)-1-piperazinyl]ethoxy} ou de sels de ceux-ci

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106187920A (zh) * 2016-07-15 2016-12-07 苏州东瑞制药有限公司 一种盐酸左西替利嗪片的有关物质及其分析检测方法

Also Published As

Publication number Publication date
WO2009062036A2 (fr) 2009-05-14

Similar Documents

Publication Publication Date Title
WO2009084024A3 (fr) Procédé pour la préparation de r-sitagliptine et de ses sels pharmaceutiquement acceptables
NO2017036I1 (no) Daklatasvir og farmasøytisk akseptable salter derav, spesielt daklatasvir dihydroklorid
EP2358691B8 (fr) Procede de preparation de composes de piperazine et sels hydrochlorures de ceux-ci
EP2220093A4 (fr) Procédés de préparation de sitagliptine et sels pharmaceutiquement acceptables de celle-ci
WO2009062044A3 (fr) Procédés de préparation de prasugrel et ses sels et polymorphes
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
WO2010117738A3 (fr) Formes à l'état solide de sels de sitagliptine
HU0700339D0 (en) New piperazine salts and process for their preparation
WO2011076212A3 (fr) Procédés de fabrication d'un principe pharmaceutiquement actif
IL206394A (en) Derivatives of 2-Benzylpyridine Filtration as Met Kinase Inhibitors, Process for their Preparation, Medication and Use
WO2009025873A3 (fr) Procédés pour la préparation de formes cristallines a, b et d'une forme a cristalline pure de chlorhydrate d'erlotinib
WO2008120080A3 (fr) Procédé amélioré de synthèse de solifénacine
IL212639A0 (en) Piperazine salt and a process for the preparation thereof
WO2008021410A3 (fr) Diacide de pemetrexed de haute pureté et ses procédés de préparation
PL2106225T3 (pl) Pościel aromaterapeutyczna i sposób jej wytwarzania
EP4349369A3 (fr) Augmentation de la biodisponibilité de médicaments dans une thérapie par naltrexone
WO2009022327A3 (fr) Nouveau procédé de préparation de lévocétirizine de pureté élevée et de ses sels
WO2008051539A3 (fr) Processus de préparation de sels de palonosetron
WO2009149058A3 (fr) Formulations de niacine à libération modifiée
WO2010148314A3 (fr) Préparation d'ésoméprazole et de ses sels pharmaceutiquement acceptables
WO2008037258A8 (fr) [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]méthyle amine destinée au traitement de troubles affectifs
AU2008306604A8 (en) Process for the preparation of zolmitriptan, salts and solvates thereof
WO2011018801A3 (fr) Forme pharmaceutique orale solide de ziprasidone
ZA201000802B (en) Process for the preparation of alfuzosin hydrochloride

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08846828

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08846828

Country of ref document: EP

Kind code of ref document: A2